Highlights: EBGLYSS targets IL-13 to reduce eczema inflammation and itching FDA approval was based on successful

India has made remarkable strides in the fight against medlinkHIV/AIDS/medlink, with the country's annual medlinkHIV infections/medlink dropping

Highlights: Air pollution can increase stroke risk as much as smoking Over 80% of stroke patients live in

Urinary tract infections (UTIs) are a common issue, with half of all women likely to experience at least one in their lifetime. Many women also deal...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients unresponsive to other...

Former President Donald Trump may publicly be backing off past attempts to destroy the Affordable Care Act, at least until he has more than the...

With strong bactericidal properties, graphene has the potential to become a game changer in the fight against antibiotic-resistant bacteria.

Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis. Current treatments could be...

The recent series of coordinated explosions in Lebanon, which have been attributed to Israel, serve as a grim reminder of the dangers posed by...

Herbal supplements like ginseng, aloe vera, cinnamon, and St. John's wort can impact diabetes management by interacting with medications and...